| Literature DB >> 23632019 |
Bridget E Hawkins1, Shashirekha Krishnamurthy2, Diana L Castillo-Carranza2, Urmi Sengupta2, Donald S Prough3, George R Jackson4, Douglas S DeWitt3, Rakez Kayed5.
Abstract
Traumatic brain injury (TBI) is a serious problem that affects millions of people in the United States alone. Multiple concussions or even a single moderate to severe TBI can also predispose individuals to develop a pathologically distinct form of tauopathy-related dementia at an early age. No effective treatments are currently available for TBI or TBI-related dementia; moreover, only recently has insight been gained regarding the mechanisms behind their connection. Here, we used antibodies to detect oligomeric and phosphorylated Tau proteins in a non-transgenic rodent model of parasagittal fluid percussion injury. Oligomeric and phosphorylated Tau proteins were detected 4 and 24 h and 2 weeks post-TBI in injured, but not sham control rats. These findings suggest that diagnostic tools and therapeutics that target only toxic forms of Tau may provide earlier detection and safe, more effective treatments for tauopathies associated with repetitive neurotrauma.Entities:
Keywords: Neurodegeneration; Protein Aggregation; Protein Assembly; Protein Misfolding; Tau; Tau Aggregation; Tau Oligomers; Tauopathies; Traumatic Brain Injury
Mesh:
Substances:
Year: 2013 PMID: 23632019 PMCID: PMC3675635 DOI: 10.1074/jbc.M113.472746
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157